[Carcinoid syndrome with a course of more than 10 years].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D015282:Octreotide; D010918:Pizotyline / Q000627:therapeutic use; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010918:Pizotyline; D013004:Somatostatin; D015282:Octreotide
Carcinoid-Syndrom mit mehr als 10jährigem Verlauf.